ADVERTISEMENT
Posted: Sep 7, 2023

New treatment option for pediatric T2D

Diabetes

This past June, FDA approved the first new class of medicines to treat pediatric T2D since 2000. Previously limited to metformin, children 10 years or older with T2D now have another treatment
option that can be used in addition to diet and exercise to improve blood glucose control.

Lauren Howell, PharmD

Read more
Posted: Aug 7, 2023

Updates from FDA

New & Approved

Updates from FDA

Read more
Posted: Aug 7, 2023

Topical antibiotics and antiseptics

OTCs Today

A tube of nonprescription antibiotic ointment or bottle of antiseptic is a staple in most medicine cabinets, and for good reason. These products can prevent infection of small cuts, scrapes, or other skin injuries that don’t require medical intervention.

Mary Warner

Read more
Posted: Aug 7, 2023

Black pepper extract and CYP3A4 inhibition

On The Shelf

Piperine, a major component of black pepper (Piper nigrum), is responsible for black pepper’s distinct flavor, is what makes you sneeze, and gives black pepper its reputation for having antioxidant and antiinflammatory properties.

Mickie Cathers

Read more
Posted: Aug 7, 2023

New buprenorphine treatment option

New Drug

In May of 2023, FDA approved Brixadi (Braeburn Inc.), a new dosage form of the partial opioid agonist buprenorphine.

Lauren Howell, PharmD

Read more
First3233343537394041Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT